(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 443.32%19.81M | -262.23%-51.12M | -98.08%243K | -497.23%-12.06M | -7,658.36%-33.53M | -128.25%-5.77M | 131.00%31.51M | 135.87%12.66M | 89.11%-2.02M | 101.03%443.64K |
Net income from continuing operations | -78.07%419K | -1,035.74%-15.39M | -116.66%-7.89M | -581.42%-9.02M | -258.25%-394K | -39.64%1.91M | -87.56%1.65M | -192.92%-3.64M | -34.48%1.87M | -93.07%248.98K |
Operating gains losses | 525.00%25K | 471.43%26K | --0 | --0 | --22K | --4K | -273.22%-7K | --1K | ---46K | ---- |
Depreciation and amortization | -3.74%180K | -16.07%700K | -8.33%187K | -26.50%172K | -25.37%154K | -1.39%187K | -0.28%834K | 2.86%204K | 7.92%234K | -1.33%206.37K |
Asset impairment expenditure | ---- | 484.74%11.88M | 495.89%11.88M | ---- | ---- | ---- | 132.66%2.03M | --1.99M | ---- | ---- |
Provision for loans, leases and other losses | -11.80%411K | 195.14%24.48M | 25.18%8.31M | 9,787.92%14.44M | -34.03%1.27M | 499.68%466K | 634.11%8.29M | 1,186.22%6.64M | -74.50%-149K | 1,760.49%1.92M |
Remuneration paid in stock | 78.26%41K | -13.16%165K | -72.50%22K | 1.39%73K | 170.13%47K | 11.65%23K | 116.19%190K | 9.88%80K | 377.52%72K | --17.4K |
Deferred tax | 134.00%186K | -1,278.62%-11.8M | -696.49%-7.98M | -19,558.82%-3.34M | 109.38%72K | -222.10%-547K | -42.04%1M | 41.44%1.34M | -106.23%-17K | -280.28%-768K |
Other non cashItems | -96.22%21K | -47.94%1.05M | -84.37%209K | -0.61%326K | -124.74%-41K | 198.44%556K | 64.77%2.02M | 726.25%1.34M | 83.43%328K | -25.94%165.7K |
Change in working capital | 394.19%19.05M | -399.70%-58.56M | -177.97%-4.19M | -240.76%-14.16M | -4,348.27%-33.74M | -136.94%-6.47M | 116.69%19.54M | 113.42%5.38M | 81.43%-4.15M | 101.72%794.18K |
-Change in receivables | 4,430.04%22.47M | -241.35%-51.57M | -112.19%-5.94M | -202.05%-10.86M | -643.65%-35.27M | -97.76%496K | 130.70%36.48M | 93.30%-2.8M | 139.57%10.64M | 114.58%6.49M |
-Change in payables and accrued expense | 29.28%-1.99M | 111.18%1.35M | -15.11%3.05M | 81.56%-2.13M | 459.46%3.24M | 13.29%-2.81M | -991.12%-12.07M | 334.38%3.59M | -542.31%-11.52M | -1,118.93%-900.24K |
-Change in other current assets | 32.93%-1.62M | -110.43%-6.66M | -142.58%-1.41M | 64.37%-960K | 52.70%-1.88M | -1,379.57%-2.41M | -14,477.90%-3.16M | 555.14%3.31M | -204.07%-2.69M | -107.03%-3.97M |
-Change in other working capital | 110.28%180K | 1.23%-1.69M | -91.55%107K | 62.78%-214K | 121.08%173K | -11.09%-1.75M | -557.25%-1.71M | -21.95%1.27M | 15.97%-575K | -418.22%-820.83K |
Tax refund paid | 72.40%-523K | 9.32%-3.66M | 55.56%-292K | -177.78%-550K | 57.76%-922K | -89.99%-1.9M | -308.75%-4.04M | -1,373.16%-657K | -154.55%-198K | -40.76%-2.18M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 443.32%19.81M | -262.23%-51.12M | -98.08%243K | -497.23%-12.06M | -7,658.36%-33.53M | -128.25%-5.77M | 131.00%31.51M | 135.87%12.66M | 89.11%-2.02M | 101.03%443.64K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 45.83%-26K | -34.86%-236K | 75.00%-11K | -1,066.67%-140K | 59.70%-37K | -76.51%-48K | -110.21%-175K | -173.79%-44K | 88.81%-12K | -545.20%-91.81K |
Net PPE purchase and sale | 45.83%-26K | -34.86%-236K | 75.00%-11K | -1,066.67%-140K | 59.70%-37K | -76.51%-48K | -110.21%-175K | -173.79%-44K | 88.81%-12K | -545.20%-91.81K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 45.83%-26K | -34.86%-236K | 75.00%-11K | -1,066.67%-140K | 59.70%-37K | -76.51%-48K | -110.21%-175K | -173.79%-44K | 88.81%-12K | -545.20%-91.81K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -3,075.52%-18.6M | 215.88%43.19M | 103.55%349K | 236.39%8.39M | 24,288.70%33.83M | 102.10%625K | -130.96%-37.27M | -118.92%-9.84M | -88.80%2.5M | -100.42%-139.84K |
Net issuance payments of debt | -1,567.80%-18.6M | 224.68%45.12M | 103.80%349K | 834.44%9.04M | 5,192.93%34.47M | 104.43%1.27M | -129.30%-36.19M | -117.54%-9.19M | -95.98%967K | -98.07%651.17K |
Cash dividends paid | --0 | 25.00%-1.93M | --0 | -0.16%-643K | 0.17%-641K | -0.01%-642K | -50.02%-2.57M | -50.02%-642K | -50.02%-642K | -50.04%-642.08K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | 203.87%1.48M | ---1K | 258.48%2.17M | ---148.93K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -3,075.52%-18.6M | 215.88%43.19M | 103.55%349K | 236.39%8.39M | 24,288.70%33.83M | 102.10%625K | -130.96%-37.27M | -118.92%-9.84M | -88.80%2.5M | -100.42%-139.84K |
Net cash flow | ||||||||||
Beginning cash position | -46.89%9.7M | -24.40%18.26M | -43.84%9.36M | -19.48%12.66M | -9.24%12.98M | -24.40%18.26M | 335.42%24.15M | 120.18%16.67M | 421.82%15.73M | 5.35%14.3M |
Current changes in cash | 122.79%1.18M | -37.40%-8.16M | -79.12%581K | -920.04%-3.81M | 20.76%256K | 44.75%-5.19M | -131.85%-5.94M | -83.38%2.78M | -87.25%464K | 102.13%212K |
Effect of exchange rate changes | 54.02%-40K | -967.39%-399K | 79.55%-244K | 5.26%500K | -146.60%-568K | 80.87%-87K | 209.26%46K | -642.45%-1.19M | -48.15%475K | 306.15%1.22M |
End cash position | -16.47%10.84M | -46.89%9.7M | -46.89%9.7M | -43.84%9.36M | -19.48%12.66M | -9.24%12.98M | -24.40%18.26M | -24.40%18.26M | 120.18%16.67M | 421.82%15.73M |
Free cash from | 440.04%19.78M | -263.89%-51.35M | -98.16%232K | -500.59%-12.2M | -9,641.12%-33.57M | -128.52%-5.82M | 130.80%31.33M | 135.80%12.62M | 89.10%-2.03M | 100.81%351.84K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.